Literature DB >> 34912104

VISTA dampens T cell activation in injured kidney.

Monica Wang1.   

Abstract

Entities:  

Year:  2022        PMID: 34912104     DOI: 10.1038/s41581-021-00530-3

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.

Authors:  Mark Yarchoan; Leslie Cope; Amanda N Ruggieri; Robert A Anders; Anne M Noonan; Laura W Goff; Lipika Goyal; Jill Lacy; Daneng Li; Anuj K Patel; Aiwu R He; Ghassan K Abou-Alfa; Kristen Spencer; Edward J Kim; S Lindsey Davis; Autumn J McRee; Paul R Kunk; Subir Goyal; Yuan Liu; Lauren Dennison; Stephanie Xavier; Aditya A Mohan; Qingfeng Zhu; Andrea Wang-Gillam; Andrew Poklepovic; Helen X Chen; Elad Sharon; Gregory B Lesinski; Nilofer S Azad
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.